Phreesia PHR 深 滬
等待開盤 07-19 09:30:00 美东时间
25.28
-0.650
-2.51%
華盛通- 最 高26.135
- 今 開26.06
- 成交量 50.39万股
- 最 低 24.87
- 昨 收 25.93
- 總市值 15.04亿
- 52周最高 30.53
- 市盈率 靜 --
- 換手率 0.85%
- 52周最低 17.07
- 委 比 -64.89%
- 總股本 5950.43万
- 歷史最高 81.592
- 量 比 1.66
- 振 幅 4.88%
- 歷史最低 12.05
- 每 手 1
- 風險率 2.80%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多EnerCom Denver Releases Full Presenter Lineup for Landmark 30th Energy Investment Conference
Conference Lineup Features C-Suite Representation from over 75 Confirmed Companies Industry Panel Topics Include The Resurgence of Exploration, Private Companies, The Rise of Asset-Backed Se...
07-15 02:53
What 4 Analyst Ratings Have To Say About Phreesia
Phreesia (NYSE:PHR) has been analyzed by 4 analysts in the last three months, r...
07-14 21:01
Keybanc Maintains Overweight on Phreesia, Raises Price Target to $35
Keybanc analyst Aleksey Yefremov maintains Phreesia (NYSE:PHR) with a Overweight and raises the price target from $28 to $35.
07-14 20:37
Pharming Group reports on results of the 2025 Annual General Meeting of Shareholders
Pharming Group N.V. announced that all proposals were approved at its Annual General Meeting of Shareholders held on June 11, 2025. Dr. Elaine Sullivan was appointed to the Board of Directors, while Mrs. Jabine van der Meijs and Mr. Leonard Kruimer were reelected as Non-Executive Directors. Mrs. Deborah Jorn and Mr. Steven Baert did not stand for re-election. Shareholders also approved the renewal of Deloitte Accountants B.V. as the external audi...
06-11 15:15
美股大行评级 | 潜在涨幅746.15%！Intrusion获Ascendiant Capital升目标价至11美元，维持"买入"评级
潜在涨幅746.15%！Intrusion获Ascendiant Capital升目标价至11美元，维持"买入"评级
06-02 13:32
美股大行评级 | 英伟达、赛富时、C3.ai、Veeva Systems等获多家机构上调目标价！
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1135136987677396993.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 摩根大通：维持Cogent Biosciences(COGT)"超配"评级，目标价从21美元升至25美元</p> <p>• Chardan Capital：维持Taysha Gene Therapies(TSHA)"买入"
05-30 09:09
Canaccord Genuity Maintains Buy on Phreesia, Lowers Price Target to $34
Canaccord Genuity analyst Richard Close maintains Phreesia (NYSE:PHR) with a Buy and lowers the price target from $35 to $34.
05-29 21:43
Palomar Holdings, Inc. Announces Successful Completion of June 1 Reinsurance Placement
Palomar Holdings increased its 2025 adjusted net income guidance to $195 million to $205 million, reflecting successful completion of reinsurance programs and growth in its earthquake franchise. The Company added $455 million in incremental limit, expanding its earthquake coverage to $3.53 billion and hurricane coverage to $100 million. Event retentions were reduced for hurricanes to $11 million and maintained at $20 million for earthquakes. The ...
05-29 20:15
Phreesia Reports Strong Start to Fiscal 2026
Phreesia ( ($PHR) ) has released its Q1 earnings. Here is a breakdown of the in...
05-29 11:58
